SEATTLE, WA--(Marketwire -01/30/12)- Plandaí Biotechnology, Inc.
(OTC.BB:
PLPL.OB -
News) Chief Executive Officer, Roger Duffield, today
announced that Dr. Tom Matula has accepted the position
of Chairman of the Scientific Board for Plandaí Biotechnology,
Inc., effective immediately.

Dr. Matula is a world-renowned scientist and entrepreneur with
expertise in medical and industrial applications of ultrasound.
He is the author of over 40 peer-reviewed publications and has
several patents in the medical devices landscape. Dr. Matula is
a past winner of the Department of Defense Young Scientist
Award and was also awarded the Presidential Early Career Award,
the highest honor bestowed by the United States government on
science and engineering professionals in the early stages of
their careers. He has advised members of congress on energy
issues, and helps organize panels on technology transfer out of
universities.

Dr. Matula received his PhD. in Physics from Washington State
University. He currently serves as Affiliate Associate
Professor, Bioengineering and Electrical Engineering with the
University of
Washington, is the Director of the Center for Industrial
and Medical Ultrasound and the Director of the Center for
Ultrasound-based Molecular Imaging and Therapy, both with the
University of Washington. Dr. Matula also serves as Principal
Physicist with the Applied Physics Laboratory at the University
of Washington.

Dr. Matula is a co-inventor of Plandaí Biotechnology's proprietary
technology that extracts a high level of bio-available
compounds from organic matter including green tea leaves and
most other organic materials. Various tests have been conducted
over the past ten years using this technology that generates
functional chemical compounds possessing nutritive properties
that act effectively as preventive agents in the healthcare
field. Polyphenols from green tea are an excellent source of
antioxidant and anti-carcinogenic substances. Dr.Matula has
been instrumental in bringing this technology to market through
Plandaí Biotechnology.

Mr. Duffield commented, "Plandaí is delighted that Dr. Matula
has accepted the chair position as we have been working
together on the science behind our company for over 10 years.
As a scientist, he brings a wealth of experience and insight as
we transition from research into market-ready products. Plandaí
Biotechnology intends to continue adding highly qualified and
experienced professionals to our Scientific Advisory Board. Dr.
Matula's leadership as the Chairman of our Scientific Board
demonstrates the acceptance within the scientific community of
our technology."

Additional information on Dr. Matula's background can be found
at:
http://www.apl.washington.edu/people/profile.php?last=Matula&first=Tom.

About Plandaí Biotechnology, Inc.

Plandaí Biotechnology, Inc., through its recent acquisition of
Global Energy Solutions, Ltd. and its subsidiaries, focuses on
the farming of whole fruits, vegetables and live plant material
and the production of proprietary functional foods and
botanical extracts for the health and wellness industry. Its
principal holdings consist of land, farms and infrastructure in
South Africa.

Go here to read the rest:
Plandai Biotechnology, Inc. Announces Appointment of World-Renowned Physicist to Chair Plandai Scientific Board